ChEMBL ID: CHEMBL1743086
Mechanism of action: Integrin alpha-2 antagonist
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Trials and conditions connected to VATELIZUMAB